For millions of Americans, bathroom trips bring anxiety rather than relief. Irritable bowel syndrome with constipation (IBS-C) impacts approximately one-third of all IBS cases, causing physical ...
Ardelyx presented data on IBSRELA® at the Digestive Disease Week Conference, highlighting safety, tolerability, and financial impact for IBS patients. Ardelyx, Inc. announced at the Digestive Disease ...
WALTHAM, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. An AGA survey found that IBS symptoms disrupt patients’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results